Cargando…

Long-term Dalbavancin for Suppression of Gram-Positive Chronic Left Ventricular Assist Device Infections

BACKGROUND: Infection is the leading cause of morbidity and mortality in patients with left ventricular assist devices (LVADs). Prolonged suppressive therapy should be strongly considered and is often used in patients with recurrent infections when source control cannot be achieved. Dalbavancin is a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rowe, Sarah, Green, Sarah, Albrecht, Benjamin, Pouch, Stephanie M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673638/ https://www.ncbi.nlm.nih.gov/pubmed/38023541 http://dx.doi.org/10.1093/ofid/ofad537

Ejemplares similares

Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report
por: Howard-Anderson, Jessica, et al.
Publicado: (2019)

Management of Bloodstream Infections in Left Ventricular Assist Device Recipients: To Suppress, or Not to Suppress?
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2020)

2765. Dalbavancin for challenging left ventricular assist device driveline infections
por: Doligalski, Christina, et al.
Publicado: (2023)

Management and Outcome of Left Ventricular Assist Device Infections in Patients Undergoing Cardiac Transplantation
por: Esquer Garrigos, Zerelda, et al.
Publicado: (2020)

1553. Efficacy and Safety of Dalbavancin and Oritavancin in the Treatment of Gram-Positive Infections
por: Brown, Vanessa, et al.
Publicado: (2020)

200. Real-World Experience with Dalbavancin for Complicated Gram-Positive Infections: A Multicenter Evaluation
por: Alosaimy, Sara, et al.
Publicado: (2019)

Left Ventricular Assist Device: Review of Antimicrobial Prophylaxis Strategies and Incidence of Infections at a Tertiary Care Center 12-Year Experience
por: Mendoza, Maria Alejandra, et al.
Publicado: (2023)

Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for Staphylococcus aureus Bloodstream Infections
por: Molina, Kyle C, et al.
Publicado: (2022)

Dalbavancin as long-term suppressive therapy for patients with Gram-positive bacteremia due to an intravascular source—a series of four cases
por: Hitzenbichler, Florian, et al.
Publicado: (2020)

687. Use of Dalbavancin in Gram-positive Infective Endocarditis: Review of Current Literature
por: Fazili, Tasaduq, et al.
Publicado: (2021)

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
por: Rappo, Urania, et al.
Publicado: (2018)

Effectiveness of Dalbavancin Compared With Standard of Care for the Treatment of Osteomyelitis: A Real-world Analysis
por: Cain, Alexander R, et al.
Publicado: (2021)

Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections
por: Smith, Jordan R., et al.
Publicado: (2015)

Use Of Prone Positioning In Patients With Left Ventricular Assist Devices
por: Stewart, Scott, et al.
Publicado: (2022)

Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin
por: Oliva, Alessandra, et al.
Publicado: (2021)

Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series
por: Evins, Connor, et al.
Publicado: (2022)

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection in Patients With Obesity or Diabetes: A Subgroup Analysis of Pooled Phase 3 Clinical Trials
por: Riccobene, Todd, et al.
Publicado: (2023)

In Vitro Activity of Essential Oils Against Gram-Positive and Gram-Negative Clinical Isolates, Including Carbapenem-Resistant Enterobacteriaceae
por: Patterson, Jan E, et al.
Publicado: (2019)

712 Gram-negative associated Ventricular Assist Device infections
por: Patel, Ami, et al.
Publicado: (2014)

Risk of Cardiovascular Implantable Electronic Device Infection in Patients Presenting With Gram-Negative Bacteremia
por: Chesdachai, Supavit, et al.
Publicado: (2022)

Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections
por: Bork, Jacqueline T., et al.
Publicado: (2019)

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections
por: Poliseno, Mariacristina, et al.
Publicado: (2021)

Echocardiography in Left Ventricular Assist Device
por: Helmy, Sherif M., et al.
Publicado: (2010)

Is It Actionable? An Evaluation of the Rapid PCR-Based Blood Culture Identification Panel on the Management of Gram-Positive and Gram-Negative Blood Stream Infections
por: Tseng, Andrew S, et al.
Publicado: (2018)

Oritavancin vs Standard of Care for Treatment of Nonendovascular Gram-Positive Bloodstream Infections
por: Moenster, Ryan P, et al.
Publicado: (2023)

Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices
por: Shehab, Sajad, et al.
Publicado: (2019)

Temporary Right Ventricular Assist Device Insertion via Left Thoracotomy after Left Ventricular Assist Device Implantation
por: Park, Ilkun, et al.
Publicado: (2019)

Outcomes of Hospitalizations for Cardiogenic Shock at Left Ventricular Assist Device Versus Non–Left Ventricular Assist Device Centers
por: Wang, Joseph I., et al.
Publicado: (2020)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

The influence of left ventricular assist device inflow cannula position on thrombosis risk
por: Ghodrati, Mojgan, et al.
Publicado: (2020)

Left Ventricular Assist Device Implantation in a COVID-19 Positive Patient
por: Dib, E.P., et al.
Publicado: (2021)

Left ventricular assist device and pump thrombosis: the importance of the inflow cannula position
por: Kortekaas, Kirsten A., et al.
Publicado: (2022)

Left ventricular assist device implantation in left ventricular aneurysm: The turtleneck technique
por: Haidari, Zaki, et al.
Publicado: (2022)

2763. Evaluating the Safety and Effectiveness of Long-term Antibiotic Suppression in Patients with Left Ventricular Assist Devices
por: Hamlin, Kelsey D, et al.
Publicado: (2023)

Invasive Community-Onset Gram-Positive Infections From July 2018 Through December 2022 at 2 Children's Hospitals
por: Engstrom, Eric E, et al.
Publicado: (2023)

The diagnosis of left ventricular assist device thrombosis
por: Gerds, H.Z.R., et al.
Publicado: (2015)

Perioperative management of left ventricular assist devices
por: Sanjay, O. P.
Publicado: (2016)

Hyperkalemia in Patients With Left Ventricular Assist Devices
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Left Ventricular Assist Devices and Renal Ramifications
por: Nair, Ajith, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vfrlip8eb0kemd69k8o1j4gbch